This Biotech Stock Surged with Fresh $9M Investment
A biotech stock surged 75% last quarter and drew a new $9 million investment, signaling confidence from sophisticated...
Discover which no annual fee travel credit cards provide the highest rewards. Uncover the best options to enhance your travels.
26,108 articlesA biotech stock surged 75% last quarter and drew a new $9 million investment, signaling confidence from sophisticated...
Cramer confronted his past mega-cap bets on Mad Money, pivoting to a bullish view on Corning as supplier demand remai...
Li Lu’s Himalaya Capital is famous for a bold, value-driven stance and a striking concentration in just a few bets. T...
Three dividend ETFs stand out as 2026 nears: SCHD for cost and broad exposure, HDV for quality screening, and DGRO fo...
Robotaxi chatter tends to focus on all-or-nothing automation. This article explains why Uber's hybrid network could b...
States expand aid to middle-income buyers as mortgage costs and home prices stay elevated. The shift broadens access ...
Rivian sits at a pivotal crossroads. This in-depth look weighs cash, partnerships, and a road map for growth to answe...
Daré (DARE) has a developing pipeline and a tight cash runway. This article breaks down what the Q4 2025 earnings cal...
A new tech challenger aims to blend space, AI, and hardware into one powerful growth engine. This article breaks down...
A major fund recently reduced its exposure to Adaptive Biotechnologies, sparking questions about what institutional m...
New York City unveils a sweeping, $22 billion plan to address housing affordability. The strategy pledges 400,000 aff...
Artificial intelligence is reshaping how companies grow and compete. This guide breaks down the two best AI-focused s...